// App-Quantinova.ai

12733 : Assessment of Dual Antiplatelet Therapy versus Low-dose Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure: The Randomized Adrift Study

Researchers

Presenter

  • Guillaume Duthoit

Principal Investigators

  • Jean-Michel P Juliard

  • Antoine Lepillier

  • Batric Popovic

  • Nicolas Lellouche

  • Luc Lorgis

  • Didier Klug

  • Noura Zannad

  • Corinne Frere

  • Solohaja-Faniaha Dimby

  • Eric Vicaut

  • Delphine Brugier

  • Hui Wang

  • Ccile Kedzia

  • Marie Hauguel

  • Nassim Braik

  • Sandrine Deltour

  • Gilles Montalescot

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Left atrial appendage occlusion

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Clopidogrel bisulfate

  • Evithrom

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved